These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
559 related items for PubMed ID: 17587208
1. Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Hwang RF, Gonzalez-Angulo AM, Yi M, Buchholz TA, Meric-Bernstam F, Kuerer HM, Babiera GV, Tereffe W, Liu DD, Hunt KK. Cancer; 2007 Aug 15; 110(4):723-30. PubMed ID: 17587208 [Abstract] [Full Text] [Related]
3. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study. Langer I, Guller U, Viehl CT, Moch H, Wight E, Harder F, Oertli D, Zuber M. Ann Surg Oncol; 2009 Dec 15; 16(12):3366-74. PubMed ID: 19760047 [Abstract] [Full Text] [Related]
4. Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields. Shahar KH, Hunt KK, Thames HD, Ross MI, Perkins GH, Kuerer HM, Strom EA, McNeese MD, Meric F, Schechter NR, Sahin AA, Middleton LP, Buchholz TA. Int J Radiat Oncol Biol Phys; 2004 Jul 15; 59(4):1074-9. PubMed ID: 15234041 [Abstract] [Full Text] [Related]
5. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study. Reed J, Rosman M, Verbanac KM, Mannie A, Cheng Z, Tafra L. J Am Coll Surg; 2009 Mar 15; 208(3):333-40. PubMed ID: 19317993 [Abstract] [Full Text] [Related]
6. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. Katz A, Smith BL, Golshan M, Niemierko A, Kobayashi W, Raad RA, Kelada A, Rizk L, Wong JS, Bellon JR, Gadd M, Specht M, Taghian AG. J Clin Oncol; 2008 May 01; 26(13):2093-8. PubMed ID: 18445838 [Abstract] [Full Text] [Related]
7. Factors associated with involvement of four or more axillary nodes for sentinel lymph node-positive patients. Katz A, Niemierko A, Gage I, Evans S, Shaffer M, Smith FP, Taghian A, Magnant C. Int J Radiat Oncol Biol Phys; 2006 May 01; 65(1):40-4. PubMed ID: 16488555 [Abstract] [Full Text] [Related]
8. Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment? Port ER, Patil S, Stempel M, Morrow M, Cody HS. Cancer; 2010 Apr 15; 116(8):1987-91. PubMed ID: 20151427 [Abstract] [Full Text] [Related]
9. Axillary recurrence is low in patients with breast cancer who do not undergo completion axillary lymph node dissection for micrometastases in sentinel lymph nodes. Rayhanabad J, Yegiyants S, Putchakayala K, Haig P, Romero L, Difronzo LA. Am Surg; 2010 Oct 15; 76(10):1088-91. PubMed ID: 21105616 [Abstract] [Full Text] [Related]
10. Axillary lymph node dissection can be avoided in women with breast cancer with intraoperative, false-negative sentinel lymph node biopsies. Takei H, Kurosumi M, Yoshida T, Ishikawa Y, Hayashi Y, Ninomiya J, Tozuka K, Oba H, Inoue K, Nagai S, Saito Y, Kazumoto T, Saitoh J, Tabei T. Breast Cancer; 2010 Oct 15; 17(1):9-16. PubMed ID: 19701679 [Abstract] [Full Text] [Related]
11. The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer. Fan YG, Tan YY, Wu CT, Treseler P, Lu Y, Chan CW, Hwang S, Ewing C, Esserman L, Morita E, Leong SP. Ann Surg Oncol; 2005 Sep 15; 12(9):705-11. PubMed ID: 16079953 [Abstract] [Full Text] [Related]
12. Sentinel lymph node metastases detected by immunohistochemistry only do not mandate complete axillary lymph node dissection in breast cancer. Gray RJ, Pockaj BA, Conley CR. Ann Surg Oncol; 2004 Dec 15; 11(12):1056-60. PubMed ID: 15545503 [Abstract] [Full Text] [Related]
13. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Chagpar A, Middleton LP, Sahin AA, Meric-Bernstam F, Kuerer HM, Feig BW, Ross MI, Ames FC, Singletary SE, Buchholz TA, Valero V, Hunt KK. Cancer; 2005 Apr 15; 103(8):1581-6. PubMed ID: 15747375 [Abstract] [Full Text] [Related]
14. Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study. Wong SL, Morton DL, Thompson JF, Gershenwald JE, Leong SP, Reintgen DS, Gutman H, Sabel MS, Carlson GW, McMasters KM, Tyler DS, Goydos JS, Eggermont AM, Nieweg OE, Cosimi AB, Riker AI, G Coit D. Ann Surg Oncol; 2006 Jun 15; 13(6):809-16. PubMed ID: 16604476 [Abstract] [Full Text] [Related]
15. Predictors of non-sentinel lymph node metastasis in breast cancer patients. Goyal A, Douglas-Jones A, Newcombe RG, Mansel RE, ALMANAC Trialists Group. Eur J Cancer; 2004 Jul 15; 40(11):1731-7. PubMed ID: 15251163 [Abstract] [Full Text] [Related]
16. Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up. Takeshita T, Tsuda H, Moriya T, Yamasaki T, Asakawa H, Ueda S, Sato K, Aida S, Tamai S, Matsubara O, Hase K, Yamamoto J. Ann Surg Oncol; 2012 Apr 15; 19(4):1160-6. PubMed ID: 21989659 [Abstract] [Full Text] [Related]
17. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Shen J, Gilcrease MZ, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Francis A, Ames FC, Hunt KK. Cancer; 2007 Apr 01; 109(7):1255-63. PubMed ID: 17330229 [Abstract] [Full Text] [Related]
18. Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissection. Calhoun KE, Hansen NM, Turner RR, Giuliano AE. Am J Surg; 2005 Oct 01; 190(4):588-91. PubMed ID: 16164927 [Abstract] [Full Text] [Related]
19. The significance of immunohistochemistry positivity in sentinel nodes which are negative on haematoxylin and eosin in breast cancer. Giobuin SM, Kavanagh DO, Myers E, Doherty AO, Quinn CM, Crotty T, Evoy D, McDermott E. Eur J Surg Oncol; 2009 Dec 01; 35(12):1257-60. PubMed ID: 19497702 [Abstract] [Full Text] [Related]
20. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery. Changsri C, Prakash S, Sandweiss L, Bose S. Breast J; 2004 Dec 01; 10(5):392-7. PubMed ID: 15327491 [Abstract] [Full Text] [Related] Page: [Next] [New Search]